MUC16 and neoplasm: Ever since it was found that serum CA125 levels increased with the clinical course of some malignancies10, its use as a tumor marker has been reported in EC patients, particularly those with poor prognostic factors such recurrences, grade 3 tumors, deep myometrial invasion, LNM, and extrauterine disease.